Skip to main content

Advertisement

SpringerLink
Log in

Reovirus safety study for proliferation and differentiation of human adipose-derived mesenchymal stem cells

  • Virology
  • Published:
Journal of Microbiology Aims and scope Submit manuscript

Abstract

Naturally occurring reoviruses are live replication-proficient viruses specifically infecting human cancer cells while sparing the normal counterparts. Stem cells can be highly susceptible to viral infection due to their innate high proliferation potential and other active signaling pathways of cells that might be involved in viral tropism. In the previous study, we showed that reoviruses could adversely affect murine embryonic stem cells’ integrity in vitro and in vivo. Oncolytic viruses, delivered systemically face many hurdles that also impede their localization and infection of, metastatic tumors, due to a variety of immune and physical barriers. To overcome such hurdles to systemic delivery, several studies supported the idea that certain types of cells, including mesenchymal stem cells, might play a role as cell carriers for oncolytic viruses. Thus, it would be interesting to examine whether human adult stem cells such as human adipose-derived mesenchymal stem cells could be saved by the reoviral challenge. In this study, we report that biological activities such as proliferation and multipotency of human adipose-derived stem cells are not affected by wild-type reovirus challenge as evidenced by survival, osteogenic and adipogenic differentiation potential assays following treatment with reoviruses. Therefore, unlike murine embryonic stem cells, our study strongly suggests that human adipose-derived adult stem cells could be spared in vivo during wild-type reoviral anti-cancer therapeutics in a clinical setting. Furthermore, the results support the possible clinical use of human adipose-derived stem cells as an effective cell carrier of oncolytic reovirus to maximize their tumor tropism and anti-tumor activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Clements, D., Helson, E., Gujar, S.A., and Lee, P.W. 2014. Reovirus in cancer therapy: an evidence-based review. Oncolytic Virother. 3, 69–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Dionne, K.R., Galvin, J.M., Schittone, S.A., Clarke, P., and Tyler, K.L. 2011. Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection. J. Neurovirol. 17, 314–326.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hall, B., Dembinski, J., Sasser, A.K., Studeny, M., Andreeff, M., and Marini, F. 2007. Mesenchymal stem cells in cancer tumor–associated fibroblasts and cell-based delivery vehicles. Int. J. Hematol. 86, 8–16.

    Article  CAS  PubMed  Google Scholar 

  • Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64, 295–312.

    Article  CAS  PubMed  Google Scholar 

  • Kim, M. 2015. Naturally occurring reoviruses for human cancer therapy. BMB Rep. 48, 454–460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim, M., Egan, C., Alain, T., Urbanski, S., Lee, P., Forsyth, P., and Johnston, R.N. 2007. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells. Oncogene 26, 4124–4134.

    Article  CAS  PubMed  Google Scholar 

  • Kim, M., Garant, K.A., zur Nieden, N.I., Alain, T., Loken, S.D., Urbanski, S.J., Forsyth, P.A., Rancourt, D.E., Lee, P.W., and Johnston, R.N. 2011. Attenuated reovirus displays oncolysis with reduced host toxicity. Br. J. Cancer 104, 290–299.

    Article  CAS  PubMed  Google Scholar 

  • Kim, M., Williamson, C.T., Prudhomme, J., Bebb, D.G., Riabowol, K., Lee, P.W.K., Lees-Miller, S.P., Mori, Y., Rahman, M.M., Mc-Fadden, G., et al. 2010. The viral tropism of two distinct oncolytic viruses, reovirus, and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene 29, 3990–3996.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loken, S.D., Norman, K., Hirasawa, K., Nodwell, M., Lester, W.M., and Demetrick, D.J. 2004. Morbidity in immunosuppressed (SCID/ NOD) mice treated with reovirus (dearing 3) as an anti-cancer biotherapeutic. Cancer Biol. Ther. 3, 734–738.

    Article  CAS  PubMed  Google Scholar 

  • Park, J.W. and Kim, M. 2016. Replicating viruses for gynecologic cancer therapy. Eur. J. Gynaecol. Oncol. 37, 295–304.

    CAS  PubMed  Google Scholar 

  • Park, J.S., Kim, H.Y., Kim, H.W., Chae, G.N., Oh, H.T., Park, J.Y., Shim, H., Seo, M., Shin, E.Y., Kim, E.G., et al. 2005. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech. Ageing Dev. 126, 551–559.

    Article  CAS  PubMed  Google Scholar 

  • Power, A.T. and Bell, J.C. 2007. Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer. Mol. Ther. 15, 660–665.

    Article  CAS  PubMed  Google Scholar 

  • Power, A.T., Wang, J., Falls, T.J., Paterson, J.M., Parato, K.A., Lichty, B.D., Stojdl, D.F., Forsyth, P.A.J., Atkins, H., Bell, J.C., et al. 2007. Carrier cell-based delivery of an oncolytic virotherapy and immunotherapy. Mol. Ther. 15, 123–130.

    Article  CAS  PubMed  Google Scholar 

  • Ramig, R.F., Cross, R.K., and Fields, B.N. 1977. Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J. Virol. 22, 726–733.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rosen, L., Evans, H.E., and Spickard, A. 1963. Reovirus infections in human volunteers. Am. J. Hyg. 77, 29–37.

    CAS  PubMed  Google Scholar 

  • Sen, A., Lea-Currie, Y.R., Sujkowska, D., Franklin, D.M., Wilkison, W.O., Harvorsen, Y.D.C., and Gimble, J.M. 2001. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J. Cell. Biochem. 81, 312–319.

    Article  CAS  PubMed  Google Scholar 

  • Smith-Franklin, B.A., Keele, B.F., Tew, J.G., Gartner, S., Szakal, A.K., Estes, J.D., Thacker, T.C., and Burton, G.F. 2002. Follicular dendritic cells and the persistence of HIV infectivity: the role of antibodies and Fc? receptors. J. Immunol. 168, 2408–2414.

    Article  CAS  PubMed  Google Scholar 

  • Stoeckel, J. and Hay, J.G. 2006. Drug evaluation: reolysin-wild-type reovirus as a cancer therapeutics. Curr. Opin. Mol. Ther. 8, 249–260.

    CAS  PubMed  Google Scholar 

  • Strong, J.E., Coffey, M.C., Tang, D., Sabinin, P., and Lee, P.W. 1988. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17, 3351–3362.

    Article  Google Scholar 

  • Tyler, K.L. 2001. Mammalian reoviruses. In Fields, B.N., Knipe, D.M., and Howley, P.M. (eds.), Fields Virology, pp. 1729–1745. Lippincott-Raven, Philadelphia, USA.

    Google Scholar 

  • Willmon, C., Harrington, K., Kottke, T., Prestwich, R., Melcher, A., and Vile, R. 2009. Cell carriers for oncolytic viruses: fed ex for cancer therapy. Mol. Ther. 17, 1667–1676.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Dankook University College of Medicine, Cheonan, 31116, Republic of Korea

    Jeong-Soo Park

  2. Department of Medical Science, Dankook University College of Medicine, Cheonan, 31116, Republic of Korea

    Manbok Kim

Authors
  1. Jeong-Soo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manbok Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manbok Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, JS., Kim, M. Reovirus safety study for proliferation and differentiation of human adipose-derived mesenchymal stem cells. J Microbiol. 55, 75–79 (2017). https://doi.org/10.1007/s12275-017-6542-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12275-017-6542-0

Keywords

Search

Navigation